Cargando…
Amantadine extended-release capsules for levodopa-induced dyskinesia in patients with Parkinson’s disease
Levodopa-induced dyskinesia (LID) is a common motor complication in patients with Parkinson’s disease on chronic levodopa therapy. The management of LID is important as dyskinesia can be disabling and impair quality of life. Currently, there are limited treatment options for the medical management o...
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Dove Medical Press
2018
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5905495/ https://www.ncbi.nlm.nih.gov/pubmed/29695911 http://dx.doi.org/10.2147/TCRM.S144481 |